Otros idiomas Aarti Drugs Limited NSE India S.E.

Acciones

AARTIDRUGS

INE767A01016

Diferido NSE India S.E. Otros sitios de cotización 13:40:29 21/05/2024			Varia. Cinco días.	Varia. 1 de enero.
494,1 ^INR	+0,72 %		+4,25 %	+1,00 %

06/05	Transcript : Aarti Drugs Limited, Q4 2024 Earnings Call, May 06, 2024
03/05	Aarti Drugs Limited informa de los resultados del cuarto trimestre finalizado el 31 de marzo de 2024	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Aarti Drugs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	03/05
Aarti Drugs Limited Reports Earnings Results for the Full Year Ended March 31, 2024	03/05
Aarti Drugs Limited Announces Executive Cessation	29/03
Aarti Drugs Begins Manufacturing Dermatology Products in Tarapur, India Facility	31/01
Aarti Drugs Limited Initiates Commercial Production of Dermatology Product At New Facility in Tarapur, Maharashtra	30/01
Aarti Drugs Limited Announces Interim Dividend for the Financial Year 2023- 24	24/01
Aarti Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	24/01
Aarti Drugs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	19/10/23
Tranche Update on Aarti Drugs Limited's Equity Buyback Plan announced on July 21, 2023.	28/08/23
Aarti Drugs Limited's Equity Buyback announced on July 21, 2023, has closed with 665,000 shares, representing 0.72% for INR 598.5 million.	17/08/23
Aarti Drugs Clocks Gains in Fiscal Q1 Consolidated Profit	24/07/23
Aarti Drugs Limited announces an Equity Buyback for 665,000 shares, representing 0.72% for INR 598.5 million.	21/07/23
Aarti Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	21/07/23
Aarti Drugs Limited authorizes a Buyback Plan.	21/07/23
Aarti Drugs Limited's Board intends to launch an Equity Buyback on July 21, 2023.	14/07/23
Aarti Drugs Limited's Board intends to launch an Equity Buyback on July 21, 2023.	14/07/23
Aarti Drugs' Consolidated Profit Climbs in Fiscal Q4	01/05/23
Aarti Drugs Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	29/04/23
Aarti Drugs' Consolidated Net Profit Declines in Fiscal Q3	30/01/23
Aarti Drugs Limited Declares Interim Dividend for the Financial Year 2022-23	27/01/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Aarti Drugs Limited NSE India S.E.

Acciones

AARTIDRUGS

INE767A01016

Otros idiomas

Filtros